168 related articles for article (PubMed ID: 18403025)
1. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis.
Vaknin-Dembinsky A; Murugaiyan G; Hafler DA; Astier AL; Weiner HL
J Neuroimmunol; 2008 Mar; 195(1-2):140-5. PubMed ID: 18403025
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D/CD46 Crosstalk in Human T Cells in Multiple Sclerosis.
Killick J; Hay J; Morandi E; Vermeren S; Kari S; Angles T; Williams A; Damoiseaux J; Astier AL
Front Immunol; 2020; 11():598727. PubMed ID: 33329593
[TBL] [Abstract][Full Text] [Related]
3. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production.
Vaknin-Dembinsky A; Balashov K; Weiner HL
J Immunol; 2006 Jun; 176(12):7768-74. PubMed ID: 16751425
[TBL] [Abstract][Full Text] [Related]
4. Myeloid dendritic cells exhibit defects in activation and function in patients with multiple sclerosis.
Haas J; Schwarz A; Korporal-Kuhnke M; Jarius S; Wildemann B
J Neuroimmunol; 2016 Dec; 301():53-60. PubMed ID: 27836182
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-beta.
Aung LL; Fitzgerald-Bocarsly P; Dhib-Jalbut S; Balashov K
J Neuroimmunol; 2010 Sep; 226(1-2):158-64. PubMed ID: 20621365
[TBL] [Abstract][Full Text] [Related]
6. TCR-stimulated changes in cell surface CD46 expression generate type 1 regulatory T cells.
Ni Choileain S; Hay J; Thomas J; Williams A; Vermeren MM; Benezech C; Gomez-Salazar M; Hugues OR; Vermeren S; Howie SEM; Dransfield I; Astier AL
Sci Signal; 2017 Oct; 10(502):. PubMed ID: 29066539
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of neuroinflammation: enhanced cytotoxicity and IL-17 production via CD46 binding.
Yao K; Graham J; Akahata Y; Oh U; Jacobson S
J Neuroimmune Pharmacol; 2010 Sep; 5(3):469-78. PubMed ID: 20661655
[TBL] [Abstract][Full Text] [Related]
8. CD46 plasticity and its inflammatory bias in multiple sclerosis.
Ni Choileain S; Astier AL
Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):49-59. PubMed ID: 21267793
[TBL] [Abstract][Full Text] [Related]
9. CCL2 induction by 1,25(OH)2D3 in dendritic cells from healthy donors and multiple sclerosis patients.
Sanseverino I; Rinaldi AO; Purificato C; Cortese A; Millefiorini E; Gessani S; Gauzzi MC
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():102-5. PubMed ID: 24184699
[TBL] [Abstract][Full Text] [Related]
10. Atypical activation of dendritic cells by
Götz A; Tang MS; Ty MC; Arama C; Ongoiba A; Doumtabe D; Traore B; Crompton PD; Loke P; Rodriguez A
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):E10568-E10577. PubMed ID: 29162686
[TBL] [Abstract][Full Text] [Related]
11. Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients.
Bartosik-Psujek H; Stelmasiak Z
J Neural Transm (Vienna); 2005 Jun; 112(6):797-803. PubMed ID: 15480850
[TBL] [Abstract][Full Text] [Related]
12. Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions.
Ambrosini E; Remoli ME; Giacomini E; Rosicarelli B; Serafini B; Lande R; Aloisi F; Coccia EM
J Neuropathol Exp Neurol; 2005 Aug; 64(8):706-15. PubMed ID: 16106219
[TBL] [Abstract][Full Text] [Related]
13. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells.
Khayrullina T; Yen JH; Jing H; Ganea D
J Immunol; 2008 Jul; 181(1):721-35. PubMed ID: 18566439
[TBL] [Abstract][Full Text] [Related]
14. T-cell regulation by CD46 and its relevance in multiple sclerosis.
Astier AL
Immunology; 2008 Jun; 124(2):149-54. PubMed ID: 18384356
[TBL] [Abstract][Full Text] [Related]
15. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
16. Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients.
Lalive PH; Kreutzfeldt M; Devergne O; Metz I; Bruck W; Merkler D; Pot C
J Neuroinflammation; 2017 Jul; 14(1):144. PubMed ID: 28738904
[TBL] [Abstract][Full Text] [Related]
17. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.
Astier AL; Meiffren G; Freeman S; Hafler DA
J Clin Invest; 2006 Dec; 116(12):3252-7. PubMed ID: 17099776
[TBL] [Abstract][Full Text] [Related]
18. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
19. Chemokine and chemokine receptor expression by liver-derived dendritic cells: MIP-1alpha production is induced by bacterial lipopolysaccharide and interaction with allogeneic T cells.
Drakes ML; Zahorchak AF; Takayama T; Lu L; Thomson AW
Transpl Immunol; 2000 Mar; 8(1):17-29. PubMed ID: 10834607
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines.
Huang YM; Xiao BG; Ozenci V; Kouwenhoven M; Teleshova N; Fredrikson S; Link H
J Neuroimmunol; 1999 Sep; 99(1):82-90. PubMed ID: 10496180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
